{
    "code": "01030054",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01030054",
    "time": "2022-12-23 06:41:27",
    "許可證字號": "衛署藥製字第030054號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/05\/25",
    "發證日期": "76\/08\/28",
    "許可證種類": "製　劑",
    "舊證字號": "01016614",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00103005404",
    "中文品名": "&quot;永信&quot;克痛肌注射液（奧菲那特林）",
    "英文品名": "ORPHENADRINE INJECTION &quot;YUNG SHIN&quot;",
    "適應症": "肌肉僵硬、疼痛、扭傷、局部肌肉損傷、椎間盤脫出、腰背痛、纖維織炎、非關節性風濕症、斜頸、骨折",
    "劑型": "270注射劑",
    "包裝": "2ML安瓿 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ORPHENADRINE CITRATE",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "0502110200  永信藥品工業股份有限公司",
    "申請商地址": "台中市大甲區頂店里中山路一段1191號",
    "主製造廠": [
        {
            "製造廠名稱": "0502110300  永信藥品工業股份有限公司台中幼獅廠",
            "製造廠廠址": "台中市大甲區日南里工九路２７號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥製字第030054號-仿單加刊賦形劑-103-01-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01030054&Seq=001&Type=9"
        }
    ]
}